Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back.

Major stock indexes ended higher for a fourth straight session Tuesday, with the S&P 500 setting a fresh closing record, ...

The Danish drugmaker will start selling a pill version of its Wegovy weight-loss medicine in January, after [securing ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Novo Nordisk A/S ADR (NVO), a trailblazer in the weight-loss revolution, has endured a bruising 2025. The Danish pharma giant ...

Weight-loss pill approval set to accelerate food industry product overhauls - Nation and World News | Hawaii Tribune-Herald ...

While patients currently must get weekly injections of the weight loss drug Wegovy, the FDA has now approved a daily pill version of the product. After spending most of his life back and forth from ...

The Food and Drug Administration has approved Wegovy in pill form. Dr. Jon LaPook has the story of one man, Dr. Chris Mertens ...

Novo Nordisk A/S is rated a Buy with improved execution and valuation gap with LLY to drive outperformance through 2026. Read ...

Appetite-suppressing GLP-1 tablets become accessible in January, and manufacturers and fast-food eateries may be pushed to alter more of their goods.